Introduction
============

One of the striking features of the injured central nervous system (CNS) is the failure of severed axons to adequately regenerate to restore loss of function. This was initially believed to be caused by an intrinsic inability of injured axons to sprout regenerative processes. However, the seminal studies of Albert Aguayo and others using peripheral or cellular tissue grafts transplanted into the lesioned spinal cord have clearly demonstrated that the environment of the injured CNS is a critical determinant of whether injured axons can regenerate \[[@b1]\]. The molecular determinates of the inhibitory CNS environment are now well-understood, with major players being myelin-associated molecules (such as nogo, myelin-associated glycoprotein) and chondroitin sulphate proteoglycans \[[@b2]\].

Equally important has been the discovery that injured neurons have an intrinsic capacity to regenerate following complete axonal transection. Although bearing the limitation of being one-dimensional, *in vitro* experimental models have proven particularly insightful in this field of research. A particular advantage of these approaches is the ability to specifically evaluate intrinsic regeneration of injured axons in the absence of glial cells or inhibitory substrates and molecules. Elegant studies have demonstrated that severance of individual axons of cultured CNS neurons results in a rapid regenerative response \[[@b3], [@b4]\]. Furthermore, axotomy of thick fasciculated axonal bundles of mature (21 days *in vitro*) clusters of cortical neurons results in regenerative sprouting within 8 hrs after injury \[[@b5], [@b6]\].

Several studies have directly investigated the precise mechanisms that underlie the intrinsic regenerative sprouting response of injured CNS neurons. Microtubule stabilizing drugs significantly alter the regenerative sprouting response following axonal transection of cortical neurons *in vitro*, indicating that cytoskeletal re-organization is a key process underlying axonal regeneration \[[@b6]\]. This has recently been confirmed by *in vivo* studies reporting that the microtubule stabilizing drug taxol facilitates axonal regeneration of the injured optic nerve \[[@b7]\]. Highlighting that the regenerative sprouting response is an active process, Verma *et al.* \[[@b8]\] have reported that protein synthesis is essential for efficient generation of regenerative growth cones following axotomy *in vitro*. They demonstrated that axotomy leads to a four- to six-fold increase in ^3^H-leucine incorporation, and that the protein synthesis inhibitors cycloheximide and anisomycin both impair the ability of severed axons to form regenerative sprouts \[[@b8]\].

To identify key molecular determinants of successful axonal regeneration, a number of studies have utilized DNA microarray techniques to reveal groups of genes that are up- or down-regulated in response to axonal injury and during axonal regeneration. These studies have implicated a wide variety of genes in the regenerative response, including cytoskeletal, cell cycle and ion homeostasis genes. A notable feature of these studies is that they have generally been undertaken within *in vivo* injury situations, such as the injured optic nerve \[[@b9], [@b10]\], sciatic nerve \[[@b11], [@b12]\] or spinal cord \[[@b13], [@b14]\]. Hence, because of the presence of glia and other cells and the inability of microarray approaches to discriminate cell-specific gene expression, these studies do not give a clear indication of the key genes directly responsible for intrinsic regenerative sprouting of injured neurons. To address this, we have undertaken a microarray study following complete axonal severance of mature (21 days *in vitro*) cultured cortical neurons.

Materials and methods
=====================

Cell culture preparation for rat primary cortical neuronal clusters
-------------------------------------------------------------------

All animal experimentation was performed under the guidelines stipulated by the University of Tasmania Animal Ethics Committee, which is in accordance with the Australian code of practice for the care and use of animals for scientific purposes. Cortical neuron cultures were prepared according to previously published protocols \[[@b6], [@b15], [@b16]\]. Briefly, cortical tissue was isolated from E17 hooded Wistar rat embryos and incubated in 0.1% trypsin (in HEPES buffer) for 15 min. Following trituration and filtration through a 20 μm filter, neurons were plated into 12-well tissue culture plates pre-coated overnight with 1mg/ml of L-lysine in borate buffer, pH 7.4, at a cell density of 4.5 × 10^5^ cells/well. Neuronal cultures were maintained at 37°C in humidified air containing 5% CO~2~ for 21 days before experimental axotomy. Neurons were initially plated into a culture medium consisting of Neurobasal™ medium (Gibco; Life Technologies Corp., California, USA), supplemented with 10% foetal bovine serum, 0.1% B-27 supplement (Gibco), 0.1 mM L-glutamine (Gibco) and 200 U/ml gentamicin (Gibco). After 24 hrs, the media was replaced with medium lacking foetal bovine serum, and replaced every 3 or 4 days.

Axotomy of rat primary cortical neuronal clusters
-------------------------------------------------

Neurons were maintained in culture for 21 days, at which time they had formed large spherical clusters of neurons and an interconnected network of thick fasciculated bundles of axons. Using a fine blade microscalpel, axonal bundles were completely severed at approximately half way along the axonal bundles. All axonal bundles in each culture well were severed. At the appropriate time points, RNA from neuronal cells were collected, representing neurons both proximal and distal to the axotomy.

Total RNA extraction and isolation
----------------------------------

RNA from neuronal clusters was extracted at indicated time points (8, 15, 24 and 48 hrs) after axotomy and control (no axotomy) using RNeasy Mini Kit (Qiagen Cat. No. 74104) as per the manufacturer's instructions. The whole procedure was performed with RNase-free filtered pipette tips. 1.5 μl of the RNA sample was taken for spectrophotometric quantification using Nanodrop ND-1000 Version 3.2.1. Another 1 μl was used for RNA quality analysis using E-gene HDA-GT12 genetic analyser.

Real-time (RT)-PCR
------------------

Reverse transcription was carried out according to steps specified by manufacturer (Applied Biosystems Taqman reverse transcription reagents; Life Technologies Corp.). Each cDNA sample was duplicated with two No Template Control (NTC) for each probe used. All genes tested were normalized against either of the internal loading controls, 18S rRNA or GAPDH. Twenty microlitres of the Taqman master mix was pipetted to the bottom of each well of the optical 96-well fast reaction plate. Five microlitres of cDNA or water (NTC) was added to the designated reaction well. The plate was then read by the 7000 Fast Real-Time PCR System with conditions according to the manufacturer's protocol.

DNA microarray
--------------

Transcriptomic profiling was performed on Illumina Rat Ref12 Ver.1 arrays for rat neuronal clusters 8, 15, 24 and 48 hrs after axonal severance. Six biological replicates were obtained for the control and three for each of the four time-points after injury. Five hundred nanograms of total RNA for each sample was brought up to an initial volume of 11 μl. RNA reverse transcription was performed with Illumina® TotalPrep RNA Amplification Kit and the concentration of cRNA was quantitated using the NanoDrop ND-1000. Seven hundred and fifty nanograms of cRNA topped up to 5 μl RNase-free water was mixed with 10 μl hybridization buffer. Hybridization using streptavidin-Cy3 labelling was carried out according to the manufacturer's instruction (Illumina Inc., San Diego, USA). Subsequently, the beadchip was read on the Illumina scanner using Bead Studio software at Scan Factor = 0.65.

Microarray data collection and analysis
---------------------------------------

Analysis of the scanned images was performed with BeadScan (Illumina Inc.). Signal data generated from the Illumina® Bead Studio software was analysed using GeneSpring^©^ v7.3 software. All differentially expressed genes in this study were selected based on the following parameters: (1) a minimum of ±1.5 fold change in at least one of post-injury time-points and (2) passed the statistical screening test of one-way ANOVA (*P* \< 0.05) and Benjamini-Hochberg False Discovery Rate Correction. Genes which were differentially expressed were annotated according to Gene Ontology Biological process with the use of an online bioinformatics resource namely Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.7 (<http://david.abcc.ncifcrf.gov/>) \[[@b17], [@b18]\]. All microarray data reported here are described in accordance with MIAME guidelines, and have been deposited in NCBIs Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/>) and are accessible through GEO Super-Series accession number GSE 23653.

Statistical analysis
--------------------

All experiments were repeated at least three times. Data were analysed using *post-hoc* Tukey test with one-way ANOVA to assess significant differences in multiple comparisons. Values of *P* \< 0.05 were considered as statistically significant and presented as mean ± S.E.

Results
=======

DNA microarray analysis
-----------------------

Gene expression profiles were obtained for 8, 15, 24 and 48 hrs post severance of axon bundles connecting rat neuronal clusters in culture. Genes with a minimum fold change of ±1.5 for at least one of the four time points were classified as differentially regulated and subjected to one-way ANOVA analysis. Those that reached significance with a *P* \< 0.05 were subjected to grouping using the online bioinformatics resource DAVID. A total of 305 genes were identified and each of them was then classified into one out of the 14 functional clusters identified to avoid overestimation ([Table 1](#tbl1){ref-type="table"}). [Figure 1](#fig01){ref-type="fig"} summarizes the number of identified genes in each biological process and the percentage these genes within the group occupied out of the total. Differences between up and down regulated genes across the four time points after axotomy were presented in [Figure 2A and B](#fig02){ref-type="fig"}, respectively. Generally, even though the genomic profiles across time were quite similar, it was evident from [Figure 2A](#fig02){ref-type="fig"} that there was a slight transient elevation of genes involved in certain biological processes such as axogenesis, morphogenesis, actin and cytoskeleton organization, cell cycle, response to oxidative stress, inflammation and chemotaxis at 8 hrs in comparison to the later time points and this was conversely true for the down-regulated genes as seen in [Figure 2B](#fig02){ref-type="fig"}.

![Pie chart annotating number and percentage of genes identified in each of the 14 biological processes. A total of 305 statistically significant regulated genes were identified by DAVID. Each gene was classified into one of its most relevant biological processes categorized according to Gene Ontology to avoid overestimation.](jcmm0016-0789-f1){#fig01}

![Comparison of biological processes associated with axotomized neurons across 8, 15, 24 and 48 hrs post-injury. Bar chart shows the distribution of up-regulated (A) and down-regulated (B) genes. Differentially transcribed genes involved in the number count were statistically significant. Overall, the genomic profiles for particular biological processes at 8 hrs were slightly distinct as compared to the other time points.](jcmm0016-0789-f2){#fig02}

###### 

Gene profiles of neuronal clusters *in vitro*, 8, 15, 24 and 48 hrs after axon severance (*P* \< 0.05)

                                                                                                                                                                         **Time**                                                
  ------------------------------------------------------ -------------- ------------------------------------------------------------------------------------------------ ---------- ------ ------- ------ ------- ------ ------- ------
  Regulation of axonogenesis                                                                                                                                                                                                     
  NM_013191                                              S100b          S100 protein, polypeptide                                                                        6.57       2.62   7.94    2.10   5.81    2.44   8.52    2.37
  NM_013166                                              Cntf           Ciliary neurotrophic factor                                                                      4.06       1.73   5.76    1.75   4.33    2.04   5.30    3.02
  NM_012809                                              Cnp1           Cyclic nucleotide phosphodiesterase 1                                                            2.52       1.83   3.69    1.28   2.87    1.39   3.44    1.01
  NM_138828                                              Apoe           Apolipoprotein E                                                                                 2.00       0.54   2.30    0.69   2.27    0.68   2.28    0.81
  XM_236640                                              Plxnb1         Plexin B1 (predicted)                                                                            1.96       0.63   2.53    0.71   2.23    0.68   2.15    0.57
  NM_017026                                              Mbp            Myelin basic protein                                                                             1.85       1.42   2.40    1.34   1.48    0.44   2.11    0.68
  NM_013001                                              Pax6           Paired box gene 6                                                                                1.81       0.52   1.80    0.50   1.70    0.50   1.88    0.62
  NM_199407                                              Unc5c          Unc-5 homologue C                                                                                1.79       0.56   1.75    0.49   1.46    0.43   1.35    0.41
  NM_012829                                              Cck            Cholecystokinin                                                                                  1.78       1.59   −2.05   0.98   1.37    1.99   −1.32   0.91
  NM_031066                                              zygin I,Fez1   Fasciculation and elongation protein                                                             1.51       0.41   1.58    0.47   1.73    0.46   1.59    0.63
  NM_181086                                              Tnfrsf12a      Tumour necrosis factor receptor superfamily, member 12a                                          1.46       0.43   −1.56   0.21   −1.18   0.50   −1.67   0.29
  XM_217250                                              Ephb1          Eph receptor B1                                                                                  1.40       0.46   2.31    0.67   1.85    0.63   1.40    0.46
  XM_236203                                              Dscaml1        Down syndrome cell adhesion molecule-like 1 (predicted)                                          1.29       0.40   1.60    0.54   1.37    0.44   1.21    0.35
  XM_222794                                              Tnn            Tenascin N (predicted)                                                                           1.19       1.18   −1.30   0.22   −1.22   0.34   −1.54   0.19
  NM_012934                                              Dpysl3         Dihydropyrimidinase-like 3                                                                       −1.38      0.22   −1.67   0.20   −2.10   0.17   −2.14   0.12
  NM_012610                                              Ngfr           Nerve growth factor receptor (member 16)                                                         −1.38      0.18   −1.57   0.18   −1.62   0.16   −1.31   0.24
  XM_341201.2                                            Epha5          Eph receptor A5 (predicted)                                                                      −1.39      0.40   −3.12   0.19   −2.06   0.29   −2.74   0.10
  NM_023023                                              Dpysl5         Dihydropyrimidinase-like 5                                                                       −1.44      0.22   −1.72   0.18   −1.55   0.27   −1.92   0.17
  NM_019272                                              Sema4f         Semaphorin 4f                                                                                    −1.46      0.32   −2.56   0.34   −1.62   0.46   −2.74   0.32
  NM_017310                                              Sema3a         Short basic domain, secreted, semaphorin 3A                                                      −1.68      0.20   −1.84   0.17   −1.65   0.17   −1.73   0.17
  NM_031073                                              Ntf3           Neurotrophin 3                                                                                   −1.69      0.16   −1.73   0.18   −1.66   0.17   −1.80   0.16
  XM_236623                                              Sema3f         Short basic domain, secreted, semaphorin 3 F (predicted)                                         −1.81      0.16   −1.99   0.18   −2.22   0.12   −1.89   0.16
  XM_234514                                              Bcl11b         B-cell leukaemia/lymphoma 11B (predicted)                                                        −1.85      0.41   −3.78   0.24   −2.53   0.37   −4.01   0.26
  NM_019288                                              App            Amyloid (A4) precursor protein                                                                   −2.38      0.11   −2.59   0.12   −2.85   0.11   −2.89   0.14
  XM_341567.2                                            Plxdc2         Plexin domain containing 2 (predicted)                                                           −2.40      0.15   −1.62   0.19   −2.54   0.24   −2.04   0.23
  NM_145098                                              Nrp1           Neuropilin 1                                                                                     −2.55      0.13   −4.53   0.06   −3.78   0.08   −3.82   0.09
  NM_053485                                              S100a6         S100 calcium binding protein A6 (calcyclin)                                                      −5.71      0.05   −5.76   0.05   −6.93   0.04   −6.74   0.04
  Neurite development and morphogenesis                                                                                                                                                                                          
  XM_215963                                              Lama5          Laminin, ·5                                                                                      2.39       0.73   2.21    0.75   2.05    0.56   1.88    0.54
  XM_342392                                              Notch1         Notch gene homologue 1,                                                                          2.35       0.65   2.43    0.64   2.00    0.55   1.81    0.48
  NM_030997.1                                            Vgf            VGF nerve growth factor inducible                                                                2.25       0.58   1.42    0.40   1.71    0.64   1.15    0.35
  NM_053021                                              Clu            Clusterin                                                                                        1.96       0.61   2.17    0.68   1.89    0.68   2.43    0.73
  NM_053911                                              Pscd2          Pleckstrin homology, Sec7 and coiled/coil domains 2                                              1.77       0.53   1.64    0.49   1.70    0.53   1.45    0.67
  XM_221672                                              Tiam1          T cell lymphoma invasion and metastasis 1 (predicted).                                           1.66       0.60   −1.07   0.46   1.20    0.71   −1.14   0.52
  NM_031131                                              Tgfb2          Transforming growth factor, 2                                                                    1.58       0.60   1.13    0.67   1.08    0.39   1.04    0.72
  NM_012924                                              Cd44           CD44 antigen                                                                                     1.58       0.47   −1.08   0.28   −1.02   0.53   −1.11   0.40
  NM_030991                                              Snap25         Synaptosomal-associated protein 25                                                               1.18       0.93   −2.69   0.65   −1.00   1.52   −2.46   0.80
  NM_019248                                              Ntrk3          Neurotrophic tyrosine kinase, receptor, type 3                                                   1.06       0.46   −1.33   0.23   −1.18   0.27   −1.56   0.21
  NM_012731                                              Ntrk2          Neurotrophic tyrosine kinase, receptor, type 2                                                   1.03       0.32   −2.14   0.17   −1.27   0.44   −2.15   0.37
  NM_012513                                              Bdnf           Brain-derived neurotrophic factor                                                                1.01       0.68   −1.84   0.17   −1.24   0.51   −1.79   0.15
  NM_012700.1                                            Stx1b          Syntaxin 1B2 (2)                                                                                 −1.00      0.27   −1.41   0.31   −1.03   0.42   −1.51   0.35
  XM_232283                                              Plxnb1         Plexin D1 (predicted)                                                                            −1.05      0.25   −1.30   0.22   −1.19   0.24   −1.65   0.18
  NM_153470                                              Lzts1          Leucine zipper, putative tumour suppressor 1                                                     −1.12      0.73   −2.09   0.51   −1.17   0.81   −2.02   0.47
  NM_013038                                              Stxbp1         Syntaxin binding protein 1                                                                       −1.20      0.54   −2.54   0.37   −1.47   0.66   −2.62   0.35
  NM_133652                                              Cspg5          Chondroitin sulphate proteoglycan 5                                                              −1.28      0.22   −1.59   0.19   −1.55   0.21   −1.30   0.37
  XM_579472                                              Slit1          Slit homologue 1                                                                                 −1.53      0.30   −2.35   0.30   −1.56   0.45   −2.91   0.17
  NM_019334                                              Pitx2          Paired-like homeodomain transcription factor 2                                                   −1.53      0.18   −1.54   0.20   −1.54   0.19   −1.44   0.19
  NM_017237                                              Uchl1          Ubiquitin carboxy-terminal hydrolase L1                                                          −1.60      0.35   −2.32   0.27   −1.75   0.32   −2.56   0.31
  NM_012548                                              Edn1           Endothelin 1                                                                                     −1.61      0.19   −1.78   0.21   −1.80   0.16   −1.71   0.17
  NM_134331                                              Epha7          Eph receptor A7                                                                                  −1.65      0.18   −1.53   0.22   −1.52   0.23   −1.52   0.20
  XM_346464                                              Slit2          Slit homologue 2                                                                                 −1.69      0.17   −1.56   0.18   −1.83   0.17   −1.88   0.22
  XM_342172                                              Thbs4          Thrombospondin 4                                                                                 −1.70      0.16   −1.74   0.19   −1.95   0.15   −2.19   0.12
  XM_223820                                              Zfp312         Zinc finger protein 312 (predicted)                                                              −1.79      0.47   −3.76   0.13   −1.55   0.64   −3.10   0.10
  XM_215451                                              Cspg2          Chondroitin sulfate proteoglycan 2                                                               −1.80      0.22   −1.38   0.22   −1.94   0.17   −2.11   0.16
  XM_342591                                              Bmp7           Bone morphogenetic protein 7                                                                     −2.12      0.25   −1.27   0.23   −1.76   0.32   1.22    0.58
  NM_017089                                              Efnb1          Ephrin B1                                                                                        −2.56      0.10   −2.94   0.14   −2.86   0.10   −3.15   0.08
  NM_031321                                              Slit3          Slit homologue 3                                                                                 −2.84      0.11   −3.26   0.10   −3.19   0.09   −3.52   0.08
  NM_053595                                              Pgf            Placental growth factor                                                                          −5.49      0.05   −4.06   0.08   −5.27   0.06   −4.70   0.06
  NM_012774                                              Gpc3           Glypican 3                                                                                       −9.15      0.10   −4.92   0.06   −9.44   0.04   −5.87   0.05
  Actin filament formation                                                                                                                                                                                                       
  XM_341553                                              PRKCQ          Protein kinase C, theta                                                                          3.84       1.86   5.17    1.56   4.04    2.02   4.55    1.39
  XM_342648.2                                            N-WASP         Neural Wiskott\--Aldrich syndrome protein                                                        3.75       1.28   4.83    1.64   3.53    2.07   4.24    2.38
  XM_218617.3                                            Myh14          Myosin, heavy polypeptide 14 (predicted)                                                         2.96       0.70   3.44    0.99   2.87    0.87   2.51    1.06
  NM_019357                                              Vil2           Villin 2                                                                                         2.16       0.67   1.57    0.46   1.66    0.41   1.73    0.58
  NM_053484                                              Gas7           Growth arrest specific 7                                                                         2.15       0.96   1.14    0.75   1.65    1.52   1.10    0.54
  NM_019131                                              Tpm1           Tropomyosin 1, α                                                                                 1.94       0.58   2.03    0.64   1.76    0.47   1.84    0.94
  NM_017117.1                                            Capn3          Calpain 3                                                                                        1.7        0.5    1.89    0.62   1.49    0.49   1.53    0.42
  NM_022401.1                                            Plec1          Plectin 1                                                                                        1.68       0.42   1.72    0.51   1.43    0.37   1.18    0.40
  NM_001005889                                           Rdx            Radixi                                                                                           1.61       0.46   1.61    0.54   1.40    0.46   1.29    0.66
  NM_019167                                              Spnb3          β-Spectrin 3                                                                                     1.45       1.17   −1.73   0.69   1.22    1.53   −1.91   0.56
  XM_221196                                              Fscn2          Fascin homologue 2, actin-bundling protein (predicted)                                           1.20       0.39   1.32    0.45   1.30    0.43   1.58    0.52
  XM_236444.3                                            LOC315840      Similar to Myosin VI                                                                             1.17       0.33   1.59    0.43   1.36    0.43   1.29    0.40
  NM_030873                                              Pfn2           Profilin 2                                                                                       −1.06      0.24   −1.31   0.22   −1.14   0.24   −1.58   0.34
  XM_237115                                              Nck2           Non-catalytic region of tyrosine kinase adaptor protein 2                                        −1.08      0.39   −1.72   0.30   −1.36   0.35   −1.74   0.32
  NM_031144                                              Actb           Actin, β                                                                                         −1.30      0.24   −1.36   0.24   −1.59   0.21   −1.44   0.36
  XM_579522                                              Actn4          Actinin ·4                                                                                       −1.31      0.22   −1.65   0.17   −1.81   0.17   −1.75   0.18
  NM_013194                                              Myh9           Myosin, heavy polypeptide 9                                                                      −1.35      0.25   −1.59   0.17   −1.66   0.18   −1.42   0.20
  XM_215862                                              Dstn           Destrin (predicted)                                                                              −1.38      0.22   −1.34   0.28   −1.64   0.21   −1.55   0.37
  NM_001009689                                           Cdc42ep2       CDC42 effector protein (Rho GTPase binding) 2                                                    −1.54      0.18   −1.59   0.20   −1.83   0.16   −1.74   0.16
  NM_019289.2                                            Arpc1b         Actin-related protein 2/3 complex, subunit 1B                                                    −1.61      0.16   −1.70   0.17   −1.81   0.15   −1.92   0.16
  NM_053814                                              Mrip           Myosin phosphatase-Rho interacting protein                                                       −1.64      0.17   −2.16   0.13   −2.43   0.13   −2.78   0.14
  XM_579484                                              Evl            Ena-vasodilator stimulated phosphoprotein                                                        −1.79      0.14   −2.45   0.14   −1.96   0.19   −2.88   0.17
  NM_019212                                              Acta1          Actin, α1, skeletal muscle                                                                       −1.91      0.16   −2.27   0.40   −2.22   0.21   −2.49   0.42
  NM_023992                                              Gpr54          G protein-coupled receptor 54                                                                    −2.05      0.16   −2.10   0.13   −2.01   0.15   −2.07   0.14
  XM_579179                                              Arhe           Ras homologue gene family, member E                                                              −2.21      0.13   −2.45   0.13   −2.45   0.13   −2.62   0.14
  NM_001007554                                           Cal            CSX-associated LIM                                                                               −4.19      0.08   −4.57   0.06   −4.66   0.07   −3.90   0.08
  NM_012722                                              Eln            Elastin                                                                                          −4.62      0.12   −3.69   0.12   −4.63   0.09   −3.98   0.08
  NM_012893.1                                            Actg2          Actin, γ2                                                                                        −33.7      0.01   −28.1   0.01   −22.3   0.03   −26.5   0.01
  Microtubule cytoskeleton organization and biogenesis                                                                                                                                                                           
  XM_341694.2                                            Dncl2b         Dynein, cytoplasmic, light chain 2B (predicted)                                                  20.8       6.64   23.8    7.22   16.4    13.4   22.5    10.6
  NM_053508                                              Tekt1          Tektin 1                                                                                         6.81       2.11   8.84    2.55   6.01    4.81   8.01    4.91
  NM_001007726                                           Dnai2          Dynein, axonemal, intermediate polypeptide 2                                                     6.65       2.05   8.07    2.65   5.66    3.42   6.58    3.78
  XM_224615.3                                            Dnah1          Dynein, axonemal, heavy polypeptide 1                                                            4.83       1.30   7.20    2.05   5.82    3.20   5.22    2.69
  XM_576475.1                                            vOC501059      Similar to kinesin-like protein 9                                                                2.52       0.78   2.70    0.77   2.35    0.96   2.72    0.86
  NM_012935                                              Cryab          Crystallin, ·B                                                                                   2.44       1.35   2.33    0.88   2.12    0.65   2.03    1.25
  XM_234720.3                                            Dnah11         Dynein, axonemal, heavy polypeptide 11                                                           2.41       0.67   3.06    0.86   2.37    0.80   2.56    0.80
  XM_213354.3                                            Dnah9          Dynein, axonemal, heavy polypeptide 9                                                            2.02       0.67   2.45    0.82   2.03    0.82   2.30    0.79
  NM_001007004                                           Tuba4          Tubulin, ·4                                                                                      1.97       0.59   1.03    0.31   1.53    0.64   −1.08   0.52
  NM_199094.1                                            Tubb2          Tubulin, 2                                                                                       1.96       0.57   1.81    0.54   1.77    0.58   1.74    0.56
  NM_206950                                              Mig12          MID1 interacting G12-like protein                                                                1.96       0.52   2.20    0.66   2.00    0.53   1.94    0.69
  XM_575908                                              Tekt2          Tektin 2 (predicted)                                                                             1.92       0.56   2.07    0.62   1.66    0.87   2.32    0.68
  NM_031763                                              Pafah1b1       Platelet-activating factor acetylhydrolase, isoform Ib                                           1.74       0.46   1.76    0.55   1.58    0.43   1.56    0.39
  XM_218820                                              Prc1           Protein regulator of cytokinesis 1 (predicted)                                                   1.65       0.48   1.46    0.43   1.43    0.37   1.63    0.79
  NM_001009666                                           Dnalc4         Dynein, axonemal, light chain 4                                                                  1.56       0.46   1.43    0.36   1.28    0.42   1.24    0.51
  NM_001009645                                           Kif22          Kinesin family member 22                                                                         1.53       0.39   1.06    0.31   1.16    0.31   1.17    0.50
  XM_240978.3                                            Kifc3          Kinesin family member C3 (predicted)                                                             1.50       0.41   1.50    0.38   1.65    0.47   1.06    0.32
  XM_341686                                              Ap1g1          Adaptor-related protein complex 1, gamma 1 subunit                                               1.49       0.42   1.41    0.51   1.51    0.43   1.21    0.44
  NM_053618                                              Bbs2           Bardet\--Biedl syndrome 2 homologue                                                              1.45       0.37   1.58    0.48   1.44    0.43   1.44    0.45
  XM_224232                                              Cenpj          Centromere protein J                                                                             1.33       0.38   1.51    0.43   1.33    0.45   1.32    0.41
  NM_022507                                              Prkcz          Protein kinase C, zeta                                                                           1.00       0.28   −1.36   0.26   −1.11   0.40   −1.60   0.35
  NM_198752.1                                            KIFC2          Kinesin family member C2                                                                         −1.01      0.36   −2.00   0.38   −1.26   0.74   −2.40   0.27
  NM_053947                                              Mark1          MAP/microtubule affinity-regulating kinase 1                                                     −1.11      0.25   −1.55   0.22   −1.34   0.25   −1.80   0.17
  XM_343018.2                                            Spg4           Spastic paraplegia 4 (spastin) (predicted)                                                       −1.25      0.23   −1.38   0.21   −1.43   0.19   −1.68   0.25
  NM_024346                                              Stmn3          Stathmin-like 3                                                                                  −1.43      0.37   −2.39   0.30   −1.56   0.48   −2.66   0.28
  NM_133320                                              Ndel1          nudE nuclear distribution gene E homologue like 1                                                −1.60      0.18   −2.32   0.12   −1.79   0.20   −2.55   0.20
  XM_215469                                              Map1b          Microtubule-associated protein 1b                                                                −1.63      0.35   −2.22   0.18   −2.12   0.23   −2.74   0.17
  NM_017166                                              Stmn1          Stathmin 1                                                                                       −2.11      0.25   −2.84   0.21   −2.29   0.28   −3.10   0.17
  Apical protein localization                                                                                                                                                                                                    
  XM_223229                                              Shrm           PDZ domain actin binding protein Shroom                                                          1.67       0.52   1.74    0.57   1.45    0.53   1.55    0.48
  XM_222896                                              Ltap           Loop tail associated protein (predicted)                                                         1.41       0.52   1.48    0.35   1.23    0.54   1.33    0.55
  **Cell cycle**                                                                                                                                                                                                                 
  NM_053749                                              Aurkb          Aurora kinase B                                                                                  4.99       1.95   5.90    1.71   4.01    1.58   5.80    1.65
  XM_574943                                              Ccna1          Cyclin A1 (predicted)                                                                            3.94       1.18   4.67    1.39   3.01    1.56   3.69    1.88
  XM_573172                                              Pnutl2         Peanut-like 2 (predicted)                                                                        3.33       1.34   3.48    1.10   2.47    1.18   2.79    2.11
  XM_579390                                              Hrasls3        HRAS-like suppressor                                                                             3.29       1.20   4.37    1.23   3.32    1.57   4.59    1.43
  XM_220423                                              Sept8          Septin 8 (predicted)                                                                             2.40       1.16   1.88    1.06   2.26    1.05   1.71    1.41
  NM_053677                                              Chek2          Protein kinase Chk2                                                                              2.33       0.84   2.58    0.75   1.91    0.70   2.45    1.03
  NM_021863                                              Hspa2          Heat shock protein 2                                                                             2.17       0.64   2.09    0.59   1.62    0.48   2.12    0.74
  XM_215222                                              Cetn2          Centrin 2                                                                                        2.15       0.60   2.43    0.71   1.97    0.81   2.15    1.16
  XM_574892                                              E2f5           E2F transcription factor 5                                                                       1.86       0.54   1.54    0.45   1.69    0.51   1.44    0.45
  NM_001005765                                           Rap1a          RAS-related protein 1a                                                                           1.76       0.54   1.65    0.45   1.49    0.49   1.49    0.41
  XM_579383                                              vOC501059      Adenylate cyclase activating polypeptide 1                                                       1.74       1.96   −1.90   0.30   1.14    2.35   −2.01   0.25
  NM_001004107                                           Tacc1a         Transforming, acidic coiled-coil containing protein 1a                                           1.58       0.47   1.51    0.42   1.48    0.40   1.20    0.47
  NM_133396                                              Tesk2          Testis-specific kinase 2                                                                         1.50       0.44   1.34    0.40   1.35    0.40   1.33    0.36
  NM_138873                                              Nbn            Nibrin                                                                                           1.50       0.49   1.26    0.32   1.37    0.42   1.16    0.37
  NM_013058                                              Id3            inhibitor of DNA binding 3                                                                       1.21       0.31   1.53    0.40   1.44    0.41   1.30    0.35
  XM_579239                                              RT1-CE7        RT1 class I, CE7                                                                                 1.20       0.37   1.62    0.70   1.09    0.29   1.39    0.42
  NM_021739                                              Camk2b         Calcium/calmodulin-dependent protein kinase II subunit                                           1.16       0.51   −2.35   0.33   −1.22   0.73   −2.37   0.43
  XM_341907                                              Eif4g2         Eukaryotic translation initiation factor 4, gamma 2                                              −1.16      0.28   −1.35   0.26   −1.56   0.21   −1.32   0.38
  XM_342804                                              Ccne2          Cyclin E2 (predicted)                                                                            −1.40      0.20   −1.50   0.19   −1.51   0.21   −1.39   0.21
  XM_222157                                              Kntc1          Kinetochore associated 1 (predicted)                                                             −1.41      0.24   −1.50   0.26   −1.52   0.19   −1.68   0.18
  XM_214152                                              Cdkn3          Cyclin-dependent kinase inhibitor 3 (predicted)                                                  −1.47      0.21   −1.70   0.20   −1.95   0.15   −1.76   0.25
  NM_053653                                              Vegfc          Vascular endothelial growth factor C                                                             −1.48      0.29   −1.73   0.20   −1.61   0.20   −1.77   0.31
  XM_223270                                              Ccng2          Cyclin G2 (predicted)                                                                            −1.53      0.19   −1.47   0.21   −1.57   0.20   −1.39   0.22
  NM_053703                                              Map2k6         Mitogen-activated protein kinase kinase 6                                                        −1.66      0.18   −1.51   0.17   −1.46   0.20   −1.82   0.19
  NM_021693                                              Snf1lk         SNF1-like kinase                                                                                 −1.67      0.27   −2.16   0.15   −1.84   0.33   −3.06   0.08
  NM_139087                                              Cgref1         Cell growth regulator with EF hand domain 1                                                      −1.69      0.23   −2.70   0.12   −1.86   0.27   −2.54   0.11
  NM_052807                                              Igf1r          Insulin-like growth factor 1 receptor                                                            −1.81      0.17   −2.06   0.16   −2.08   0.14   −2.52   0.11
  NM_033099                                              Ptprv          Protein tyrosine phosphatase, receptor type, V                                                   −2.37      0.11   −1.77   0.21   −2.19   0.14   −2.29   0.12
  NM_053713.1                                            Klf4           Kruppel-like factor 4                                                                            −3.30      0.15   −3.81   0.10   −3.45   0.09   −4.09   0.10
  Negative regulation of programmed cell death                                                                                                                                                                                   
  NM_053819                                              Timp1          Inhibitor of metalloproteinase 1                                                                 1.79       0.51   1.83    0.53   1.46    0.43   1.13    0.30
  XM_235497                                              Mkl1           Megakaryoblastic leukaemia (translocation) 1 (predicted)                                         1.05       0.27   −1.25   0.26   −1.09   0.31   −1.68   0.27
  NM_033230                                              Akt1           Thymoma viral proto-oncogene 1                                                                   −1.20      0.26   −1.50   0.24   −1.43   0.23   −1.49   0.30
  NM_207592                                              Gpi            Glucose phosphate isomerase                                                                      −1.34      0.19   −1.44   0.19   −1.37   0.21   −1.59   0.22
  NM_031345                                              Dsipi          Delta sleep inducing peptide, immunoreactor                                                      −1.37      0.21   −1.40   0.21   −1.69   0.18   −1.68   0.33
  XM_216377                                              Bag1           Bcl2-associated athanogene 1 (predicted)                                                         −1.48      0.20   −1.44   0.19   −1.53   0.20   −1.84   0.21
  NM_057130.1                                            Bid3           BH3 interacting (with BCL2 family) domain                                                        −1.58      0.18   −2.35   0.31   −1.74   0.27   −2.44   0.22
  NM_013083                                              Hspa5          Heat shock 70 kD protein 5                                                                       −1.64      0.16   −1.51   0.17   −1.50   0.19   −1.74   0.24
  XM_225257                                              Txndc5         Thioredoxin domain containing 5 (predicted)                                                      −1.69      0.15   −1.52   0.21   −1.67   0.16   −1.52   0.21
  NM_012992                                              Npm1           Nucleophosmin 1                                                                                  −1.72      0.16   −2.25   0.16   −2.19   0.13   −2.35   0.18
  NM_021691                                              Twist2         twist homologue 2                                                                                −2.47      0.12   −2.30   0.16   −2.63   0.10   −2.39   0.12
  XM_225940                                              Tnfaip8        Tumour necrosis factor, α-induced protein 8 (predicted)                                          −3.13      0.09   −2.37   0.14   −3.10   0.09   −2.70   0.11
  **Regulation of apoptosis**                                                                                                                                                                                                    
  NM_031970                                              Hspb1          Heat shock 27 kD protein 1                                                                       3.35       1.04   4.01    1.24   3.34    1.33   4.61    1.37
  NM_001007617                                           SNF1/AMPK      SNF1/AMP-activated protein kinase                                                                2.97       1.47   3.44    1.10   2.96    1.35   3.28    2.28
  NM_031775                                              Casp6          Caspase 6                                                                                        2.13       0.80   2.61    0.78   2.00    0.73   2.64    1.00
  NM_017180                                              Phlda1         Pleckstrin homology-like domain, family A, member 1                                              1.94       0.78   1.22    0.34   1.48    0.52   1.23    0.34
  XM_231692                                              Braf           v-raf murine sarcoma viral oncogene homologue B1                                                 1.69       0.52   1.98    0.70   1.63    0.52   1.57    0.70
  NM_139261.1                                            Hspbp1         hsp70-interacting protein                                                                        1.68       0.51   1.39    0.45   1.54    0.45   1.26    0.72
  NM_001004199                                           Tax1bp1        Tax1 (human T cell leukaemia virus type I) binding protein 1                                     1.41       0.38   1.67    0.54   1.42    0.43   1.31    0.41
  XM_579385                                              G6pdx          Glucose-6-phosphate dehydrogenase                                                                1.37       0.35   1.57    0.48   1.51    0.44   1.32    0.46
  NM_012660                                              Eef1a2         Eukaryotic translation elongation factor 1 α2                                                    1.16       0.63   −2.50   0.53   −1.10   0.94   −2.26   0.69
  XM_217191                                              Bnip2          BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP2                                            −1.24      0.25   −1.30   0.26   −1.48   0.23   −1.53   0.29
  NM_012922                                              Casp3          Caspase 3, apoptosis related cysteine protease                                                   −1.35      0.19   −1.47   0.19   −1.39   0.19   −1.51   0.21
  NM_023979                                              Apaf1          Apoptotic peptidase activating factor 1                                                          −1.40      0.21   −1.68   0.18   −1.52   0.20   −1.66   0.17
  NM_080897                                              Bnip1          BCL2/adenovirus E1B 19 kD-interacting protein 1                                                  −1.54      0.18   −1.81   0.15   −1.70   0.16   −2.00   0.15
  NM_053420                                              Bnip3          BCL2/adenovirus E1B 19 kD-interacting protein 3                                                  −1.62      0.17   −2.19   0.15   −2.10   0.14   −2.27   0.18
  NM_053736                                              Casp11         Caspase 11                                                                                       −2.31      0.14   −2.00   0.16   −2.46   0.13   −2.50   0.12
  NM_130422                                              Casp12         Caspase 12                                                                                       −2.54      0.12   −1.89   0.19   −2.52   0.12   −2.22   0.12
  NM_172336                                              Atf5           Activating transcription factor 5                                                                −2.62      0.15   −2.17   0.15   −2.14   0.20   −3.14   0.08
  Response to oxidative stress                                                                                                                                                                                                   
  NM_017014                                              Gstm1          Glutathione S-transferase, Ì1                                                                    4.46       1.35   5.22    1.76   4.07    2.04   5.46    1.62
  NM_012580                                              Hmox1          Heme oxygenase (decycling) 1                                                                     4.10       2.56   1.71    0.88   2.12    1.09   1.16    0.52
  NM_134349                                              Mgst1          Microsomal glutathione S-transferase 1                                                           2.90       0.87   3.39    1.00   3.08    1.07   2.72    0.95
  NM_012880                                              Sod3           Superoxide dismutase 3, extracellular                                                            2.38       0.73   2.51    0.58   2.36    1.05   2.64    1.00
  NM_053576                                              Prdx6          Peroxiredoxin 6                                                                                  2.21       0.66   2.64    0.83   2.65    0.99   2.93    0.83
  NM_012837                                              Cst3           Cystatin C                                                                                       2.06       0.52   2.18    0.63   2.07    0.62   2.08    0.63
  XM_214236                                              Nudt15         Nudix (nucleoside diphosphate linked moiety X)-type 15                                           1.90       0.59   1.57    0.53   1.51    0.49   1.55    0.48
  NM_017051                                              Sod2           Superoxide dismutase 2, mitochondrial                                                            1.70       0.47   1.87    0.59   1.32    0.43   1.62    0.51
  NM_017305                                              Gclm           Glutamate cysteine ligase, modifier subunit                                                      1.69       0.44   1.31    0.43   1.32    0.42   1.08    0.42
  NM_012815                                              Gclc           Glutamate-cysteine ligase, catalytic subunit                                                     1.67       0.49   1.14    0.32   1.23    0.33   −1.04   0.47
  NM_057143                                              Park7          Fertility protein SP22                                                                           1.56       0.43   1.68    0.45   1.52    0.45   1.53    0.56
  NM_012962                                              Gss            Glutathione synthetase                                                                           1.48       0.42   1.66    0.52   1.61    0.46   1.22    0.38
  NM_030826                                              Gpx1           Glutathione peroxidase 1                                                                         1.48       0.36   1.67    0.42   1.42    0.37   1.53    0.57
  NM_019354                                              Ucp2           Uncoupling protein 2                                                                             1.47       0.43   1.60    0.47   1.17    0.56   2.34    0.70
  NM_031614                                              Txnrd1         Thioredoxin reductase 1                                                                          1.46       0.47   −1.15   0.23   −1.13   0.28   −1.60   0.18
  XM_216452                                              Dhcr24         24-Dehydrocholesterol reductase (predicted)                                                      1.20       0.36   −1.41   0.27   −1.05   0.65   −1.66   0.31
  XM_579339                                              Serpine1       Serine (or cysteine) Proteinase inhibitor, clade E, member 1                                     −1.10      0.31   −1.69   0.20   −1.67   0.31   −2.11   0.13
  NM_017365                                              elfin,Pdlim1   PDZ and LIM domain 1                                                                             −1.18      0.26   −1.31   0.21   −1.62   0.21   −1.46   0.20
  NM_017258                                              Btg1           B-cell translocation gene 1, anti-proliferative                                                  −1.33      0.25   −1.32   0.22   −1.27   0.27   −1.54   0.28
  NM_031056                                              Mmp14          Matrix metalloproteinase 14 (membrane-inserted)                                                  −1.42      0.20   −1.71   0.16   −2.04   0.14   −2.01   0.13
  NM_053769                                              Dusp1          Dual specificity phosphatase 1                                                                   −1.54      0.32   −2.61   0.18   −1.73   0.36   −2.61   0.24
  XM_216403                                              Xpa            Xeroderma pigmentosum, complementation group A                                                   −1.55      0.18   −1.44   0.22   −1.57   0.20   −1.55   0.18
  NM_017025                                              Ldha           Lactate dehydrogenase A                                                                          −1.55      0.18   −2.35   0.12   −2.20   0.12   −2.45   0.12
  NM_024134                                              Ddit3          DNA-damage inducible transcript 3                                                                −2.00      0.15   −2.41   0.12   −2.38   0.12   −2.74   0.11
  NM_001008767                                           Txnip          Up-regulated by 1,25-dihydroxyvitamin D-3                                                        −3.59      0.22   −2.32   0.11   −4.98   0.22   −1.97   0.15
  NM_019292                                              Ca3            Carbonic anhydrase 3                                                                             −9.36      0.06   −5.14   0.05   −12.0   0.13   −6.89   0.08
  XM_213440                                              Col1a1         Collagen, type 1, α1                                                                             −16.8      0.02   −8.92   0.03   −19.1   0.04   −19.8   0.02
  Response to unfolded protein                                                                                                                                                                                                   
  NM_053612                                              Hspb8          Heat shock 22 kD protein 8                                                                       3.64       0.89   2.98    0.67   2.91    0.72   2.81    0.83
  XM_215549                                              OSP94          Osmotic stress protein 94 kD (predicted)                                                         3.55       1.23   3.21    0.97   3.00    0.78   2.98    1.53
  NM_138887                                              Hspb6          Heat shock protein, α-crystallin-related, B6                                                     1.98       0.58   2.25    0.69   1.89    0.69   2.03    0.92
  NM_175761                                              Hspca          HEAT shock protein 1, α                                                                          1.81       0.48   1.80    0.60   1.61    0.57   1.42    0.78
  XM_579648                                              Ero1l          Rattus norvegicus ERO1-like                                                                      −1.40      0.20   −1.53   0.20   −1.51   0.20   −1.59   0.19
  NM_031789                                              Nfe2l2         Nuclear factor, erythroid derived 2, like 2                                                      −1.53      0.21   −1.79   0.16   −1.88   0.15   −1.72   0.20
  NM_053523                                              Herpud1        Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1   −1.64      0.17   −1.57   0.18   −1.77   0.18   −1.64   0.24
  XM_579186                                              Txndc4         Thioredoxin domain containing 4 (endoplasmic reticulum)                                          −1.65      0.18   −1.56   0.18   −1.79   0.17   −1.78   0.22
  NM_022232                                              Dnajc3         Protein kinase inhibitor p58                                                                     −1.75      0.18   −1.78   0.18   −1.94   0.17   −1.99   0.21
  NM_001004210                                           Xbp1           X-box binding protein 1                                                                          −2.09      0.15   −2.32   0.12   −2.49   0.11   −2.61   0.11
  NM_001005562                                           Creb3l1        cAMP responsive element binding protein 3-like 1                                                 −7.08      0.04   −6.23   0.05   −7.43   0.04   −7.65   0.04
  **Calcium ion homeostasis**                                                                                                                                                                                                    
  NM_017333                                              Ednrb          Endothelin receptor type B                                                                       4.64       1.30   4.72    1.49   4.41    1.46   4.94    1.35
  NM_013179                                              Hcrt           Hypocretin                                                                                       3.07       2.31   3.31    1.04   2.64    1.93   4.51    1.27
  NM_017338                                              Calca          Calcitonin/calcitonin-related polypeptide, ·                                                     1.93       0.65   2.11    0.62   1.85    0.57   1.99    0.68
  XM_341418                                              Edg4           Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 4 (predicted)      1.90       0.58   2.50    0.77   2.04    0.66   1.96    1.07
  NM_031648                                              Fxyd1          FXYD domain-containing ion transport regulator 1                                                 1.83       0.70   2.46    0.81   1.88    0.80   2.88    1.20
  XM_579178                                              S100a1         S100 calcium binding protein A1                                                                  1.74       0.79   2.04    0.62   1.86    0.85   2.38    0.85
  NM_012713                                              Prkcb1         Protein kinase C, β1                                                                             1.59       0.80   −1.14   0.55   1.27    0.82   −1.24   0.68
  NM_017010                                              Grin1          Glutamate receptor, ionotropic, N-methyl D-aspartate 1                                           1.56       0.84   −1.47   0.70   1.16    1.31   −1.71   0.63
  NM_016991                                              Adra1b         Adrenergic receptor, α1b                                                                         −1.24      0.24   −1.57   0.19   −1.44   0.22   −1.72   0.16
  NM_001007235                                           Itpr1          Inositol 1,4,5-triphosphate receptor 1                                                           −1.31      0.31   −1.54   0.31   −1.44   0.31   −1.93   0.33
  NM_138535.1                                            Grip2          Glutamate receptor interacting protein 2                                                         −1.39      0.21   −1.59   0.17   −1.13   0.27   −1.81   0.18
  NM_030987                                              Gnb1           Guanine nucleotide binding protein, β1                                                           −1.42      0.21   −1.88   0.18   −1.64   0.20   −1.92   0.22
  NM_053867                                              Tpt1           Tumour protein, translationally-controlled 1                                                     −1.43      0.23   −1.53   0.21   −1.42   0.21   −1.61   0.18
  NM_021666                                              Trdn           Triadin                                                                                          −1.57      0.17   −1.58   0.19   −1.52   0.18   −1.55   0.18
  NM_031123                                              Stc1           Stanniocalcin 1                                                                                  −1.62      0.37   −1.84   0.19   −1.49   0.24   −2.10   0.25
  NM_021663                                              Nucb2          Nucleobindin 2                                                                                   −1.69      0.18   −1.67   0.21   −1.75   0.18   −1.82   0.33
  NM_023970                                              Trpv4          Transient receptor potential cation channel, subfamily V, member 4                               −1.71      0.16   −1.44   0.25   −1.72   0.17   −1.62   0.14
  NM_017022                                              Itgb1          Integrin β1 (fibronectin receptor β)                                                             −1.77      0.18   −1.87   0.21   −2.15   0.14   −2.42   0.23
  NM_012714                                              Gipr           Gastric inhibitory polypeptide receptor                                                          −2.23      0.14   −3.09   0.10   −2.34   0.18   −3.46   0.08
  NM_053936                                              Edg2           Endothelial differentiation, lysophosphatidic acid G-protein\--coupled receptor, 2               −3.13      0.28   −2.26   0.23   −3.85   0.17   −2.17   0.14
  XM_579462                                              Pln            Phospholamban                                                                                    −7.16      0.04   −6.34   0.05   −6.56   0.05   −6.18   0.04
  NM_053019                                              Avpr1a         Arginine vasopressin receptor 1A                                                                 −10.1      0.03   −9.82   0.03   −9.53   0.03   −10.9   0.03
  Vesicle transport                                                                                                                                                                                                              
  NM_053555.1                                            Vamp5          Vesicle-associated membrane protein 5                                                            1.65       0.52   2.02    0.71   1.35    0.50   1.98    0.59
  NM_057097.1                                            Vamp3          Vesicle-associated membrane protein 3                                                            1.55       0.38   1.69    0.40   1.47    0.45   1.48    0.60
  NM_138835.1                                            Syt12          Synaptotagmin 12                                                                                 1.56       0.46   1.15    0.35   1.27    0.35   1.17    0.33
  XM_343205.2                                            Syt1           Synaptotagmin 1                                                                                  1.33       1.08   −2.13   0.90   1.09    1.59   −1.96   0.85
  **Inflammatory response**                                                                                                                                                                                                      
  NM_133624.1                                            Gbp2           Guanylate nucleotide binding protein 2                                                           17.5       7.13   20.0    6.93   14.0    3.77   12.9    4.69
  NM_212466                                              Bf             B-factor, properdin                                                                              6.47       3.81   9.28    9.00   7.12    1.98   10.9    4.90
  NM_172222                                              C2             Complement component 2                                                                           3.55       0.97   4.03    1.22   3.17    0.90   4.50    1.51
  XM_215095.3                                            Gprc5b         G protein-coupled receptor, family C, group 5, member B                                          3.07       1.03   2.75    0.78   2.29    0.69   3.32    1.43
  NM_199093                                              Serping1       Serine (or cysteine) peptidase inhibitor, clade G, member 1                                      2.80       2.06   2.48    1.23   2.40    1.15   3.67    2.05
  NM_012488                                              A2m            ·2-Macroglobulin                                                                                 2.61       0.64   3.49    0.82   2.60    1.26   3.76    1.10
  NM_019363                                              Axo1           Aldehyde oxidase 1                                                                               2.53       0.70   5.69    3.33   4.03    2.37   2.83    0.84
  XM_573457.1                                            Gpr37l1        G protein-coupled receptor 37-like 1 (predicted)                                                 2.52       0.85   3.05    0.98   2.63    0.88   3.62    1.94
  NM_138502                                              Mgll           Monoglyceride lipase                                                                             2.51       1.08   2.16    0.81   2.21    0.79   2.31    0.72
  NM_152242.1                                            Gpr56          G protein-coupled receptor 56                                                                    2.42       0.73   2.16    0.53   2.23    0.64   2.10    0.68
  NM_212541                                              Ng22           Ng22 protein                                                                                     1.94       0.64   2.16    0.68   1.66    0.51   2.12    0.65
  NM_138900                                              C1s            Complement component 1, s subcomponent                                                           1.91       0.54   2.18    0.82   1.75    0.51   1.92    0.70
  NM_031351                                              Atrn           Attractin                                                                                        1.89       0.52   1.68    0.52   1.84    0.53   1.42    0.43
  NM_031007.1                                            Adcy2          Adenylate cyclase 2                                                                              1.88       0.51   1.78    0.55   1.80    0.52   1.78    0.56
  XM_579383.1                                            Adcyap1        Adenylate cyclase activating polypeptide 1 (predicted)                                           1.74       1.96   −1.90   0.30   1.14    2.35   −2.01   0.25
  NM_013157                                              Ass            Argininosuccinate synthetase                                                                     1.71       2.33   1.05    0.36   1.52    1.49   −1.05   0.30
  NM_031634                                              Mefv           MEDITERRANEAN fever                                                                              1.61       0.47   1.77    0.48   1.73    0.62   1.97    0.56
  NM_021690.1                                            Rapgef3        cAMP-regulated guanine nucleotide exchange factor I                                              1.58       0.40   1.78    0.48   1.71    0.52   1.77    0.48
  XM_579359                                              Cd59           CD59 antigen                                                                                     1.40       0.45   1.47    0.39   1.23    0.79   2.00    0.56
  NM_053734                                              Ncf1           Neutrophil cytosolic factor 1                                                                    1.32       0.42   1.18    0.44   1.36    0.74   2.06    1.32
  NM_212490                                              Atp6v1g2       ATPase, H+ transporting, V1 subunit G isoform 2                                                  1.31       0.75   −1.50   0.62   1.18    0.88   −1.50   0.78
  NM_022216.1                                            Gpr20          G protein-coupled receptor 20                                                                    1.25       0.37   1.70    0.56   1.34    0.44   1.64    0.46
  NM_153318                                              Cyp4f6         Cytochrome P450 4F6                                                                              1.21       0.30   1.51    0.39   1.25    0.37   1.42    0.41
  NM_001009353                                           Pla2g7         Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)                 1.20       0.43   1.24    0.41   1.27    0.78   1.74    1.25
  NM_024157                                              Cfi            Complement factor I                                                                              1.19       0.33   1.20    0.33   1.20    0.34   1.59    0.50
  NM_022236.1                                            Pde10a         Phosphodiesterase 10A                                                                            1.08       0.30   −1.52   0.38   −1.30   0.29   −1.70   0.36
  XM_579389                                              Tf             Transferrin                                                                                      −1.05      1.91   −1.50   0.82   −1.04   0.76   2.02    6.19
  NM_017196                                              Aif1           Allograft inflammatory factor 1                                                                  −1.15      0.56   −1.29   0.92   −1.11   1.11   1.79    1.40
  NM_024125                                              Cebpb          CCAAT/enhancer binding protein (C/EBP), β                                                        −1.25      0.21   −1.55   0.21   −1.27   0.22   −1.53   0.21
  XM_342092                                              Vars2          Valyl-tRNA synthetase 2                                                                          −1.31      0.21   −1.56   0.19   −1.38   0.19   −2.08   0.14
  NM_052809                                              Cdo1           Cysteine dioxygenase 1, cytosolic                                                                −1.34      0.23   −1.99   0.15   −1.81   0.16   −1.62   0.17
  NM_024486                                              Acvr1          Activin A receptor, type 1                                                                       −1.38      0.23   −1.46   0.21   −1.65   0.19   −1.61   0.17
  NM_012666                                              Tac1           Tachykinin 1                                                                                     −1.50      0.23   −2.32   0.14   −1.60   0.34   −2.47   0.13
  XM_239239                                              Map2k3         Mitogen-activated protein kinase kinase 3 (predicted)                                            −1.67      0.18   −2.12   0.14   −2.08   0.15   −2.46   0.15
  NM_130409                                              Cfh            Complement component factor H                                                                    −1.68      0.18   −1.25   0.25   −1.57   0.19   1.02    0.32
  XM_579400                                              Lbp            Lipopolysaccharide binding protein                                                               −1.81      0.19   −1.39   0.23   −1.63   0.21   −1.09   0.44
  XM_343169                                              And            Adipsin                                                                                          −2.07      0.14   −2.14   0.15   −1.83   0.15   −1.88   0.14
  NM_019143                                              Fn1            Fibronectin 1                                                                                    −2.22      0.17   −2.15   0.20   −2.43   0.11   −3.73   0.22
  NM_019262                                              C1qb           Complement component 1, q subcomponent, β polypeptide                                            −2.42      0.22   −2.81   0.29   −2.08   0.71   −1.38   0.54
  NM_001008524                                           C1qg           Complement component 1, q subcomponent, gamma polypeptide                                        −2.49      0.15   −2.97   0.18   −2.17   0.39   −1.44   0.47
  NM_017232                                              Ptgs2          Prostaglandin-endoperoxide synthase 2                                                            −3.59      0.16   −6.51   0.06   −3.84   0.13   −6.18   0.08
  XM_240184                                              Nfatc4         Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4 (predicted)            −15.4      0.06   −8.20   0.06   −14.8   0.04   −10.4   0.03
  **Chemotaxis**                                                                                                                                                                                                                 
  NM_031530                                              Ccl2           Chemokine (C-C motif) ligand 2                                                                   6.01       8.84   2.87    2.48   3.68    9.35   2.66    2.08
  NM_182952.2                                            Cxcl11         Chemokine (C-X-C motif) ligand 11                                                                5.24       1.72   6.02    8.94   2.80    0.81   2.34    1.31
  NM_022205                                              Cxcr4          Chemokine (C-X-C motif) receptor 4                                                               3.14       1.20   4.19    1.11   2.81    0.82   3.56    2.11
  NM_012953                                              Fosl1          Fos-like antigen 1                                                                               2.97       1.17   −1.04   0.27   1.47    1.19   1.02    0.25
  NM_001007612                                           Ccl7           Chemokine (C-C motif) ligand 7                                                                   2.80       3.76   2.09    1.76   2.01    3.77   1.56    0.75
  NM_139089                                              Cxcl10         Chemokine (C-X-C motif) ligand 10                                                                2.67       1.43   10.3    23.6   3.87    2.87   3.86    3.14
  NM_053953.1                                            Il1r2          Interleukin 1 receptor, type II                                                                  2.42       1.05   2.23    0.71   2.28    0.68   1.87    0.85
  NM_145672                                              Cxcl9          Chemokine (C-X-C motif) ligand 9                                                                 2.13       1.58   3.09    2.97   2.42    0.75   1.94    1.24
  NM_012747.2                                            Stat3          Signal transducer and activator of transcription 3                                               2.0        0.5    1.57    0.38   1.64    0.46   1.45    0.38
  NM_030845                                              Cxcl1          Chemokine (C-X-C motif) ligand 1                                                                 1.96       4.51   −1.30   0.32   1.64    4.95   1.18    1.07
  XM_234422.3                                            c-fos          c-Fos oncogene                                                                                   1.8        0.5    1.61    0.45   1.52    0.52   1.54    0.51
  NM_134455                                              Cx3cl1         Chemokine (C-X3-C motif) ligand 1                                                                1.58       0.62   1.01    0.46   1.32    0.88   −1.22   0.74
  NM_031512.1                                            Il1b           Interleukin 1β                                                                                   1.57       0.77   1.30    0.48   1.30    0.42   1.46    0.62
  NM_017020.1                                            Il6r           Interleukin 6 receptor                                                                           1.54       0.44   1.21    0.36   1.28    0.37   1.28    0.33
  NM_031116                                              Ccl5           Chemokine (C-C motif) ligand 5                                                                   1.43       0.40   2.96    2.76   1.80    0.48   3.03    2.40
  NM_139111                                              Cklf1          Chemokine-like factor 1                                                                          1.24       0.38   1.39    0.44   1.13    0.31   1.89    0.56
  NM_031643                                              Map2k1         Mitogen-activated protein kinase kinase 1                                                        1.08       0.30   −1.27   0.29   −1.14   0.22   −1.55   0.49
  XM_342823                                              Ccl27          Chemokine (C-C motif) ligand 27 (predicted)                                                      −1.12      0.28   −1.55   0.25   −1.16   0.38   −1.62   0.19
  XM_579590                                              Enpp2          Ectonucleotide pyrophosphatase/phosphodiesterase 2                                               −1.61      0.29   −1.22   0.26   −1.80   0.21   −1.59   0.18
  NM_031327                                              Cyr61          Cysteine rich protein 61                                                                         −1.65      0.24   −2.00   0.19   −1.90   0.26   −2.22   0.25
  NM_031836                                              Vegfa          Vascular endothelial growth factor A                                                             −1.69      0.16   −1.79   0.14   −1.78   0.16   −1.87   0.15
  NM_022177                                              Cxcl12         Chemokine (C-X-C motif) ligand 12                                                                −1.81      0.18   −1.71   0.17   −1.70   0.17   −1.16   0.29
  NM_001007729                                           Pf4            Platelet factor 4                                                                                −1.92      0.33   −2.98   0.10   −1.95   0.23   −2.36   0.12
  NM_012881                                              Spp1           Secreted phosphoprotein 1                                                                        −3.05      0.19   −1.86   0.29   −3.08   0.10   −1.40   0.64
  NM_019233                                              Ccl20          Chemokine (C-C motif) ligand 20                                                                  −3.09      0.44   −2.17   0.41   −1.94   0.94   −2.62   0.30

Genes with a minimum fold change of ±1.5 for at least one out of the four time points passed one-way ANOVA analysis and are significant with *P* \< 0.05. Data are expressed as fold-change ± S.E. Blue = genes that were up-regulated. Red = genes that were down-regulated.

Association of genes with biological processes
----------------------------------------------

### Neurite network associated genes

There was a down-regulation of genes responsible for repulsive axon guidance cues and their receptors that are known to limit axonal regeneration and these include *Efn*, *Sema*, *Slit*, *Bmp*, *Nrp*, *Plxd* and *Eph*. Conversely, there was an increased expression of neurite outgrowth promoting genes such as *Apoe*, *Cntf*, *Vgf* and *Lama5*. In addition, there was a transient elevation in gene expression at 8 hrs that faltered with time for *Snap*, *Tnn* and neurotrophic-associated factors such as *Nrtk* and *Bdnf.* A varied expression of genes involved in actin filament formation and microtubule organization was observed and they include *Tuba*, *Tubb*, *Acta*, *Actb*, *Spnb*, *Pfn*, *Stmn*, *Arp2/3*, *N-WASP* and *Map1b*. Our data also reflected on the importance of protein trafficking during axonal repair as genes known to facilitate this process, mainly motor (*Dnc*, *Dna*, *Kif*, *Myh*, *Tpm*) and vesicle proteins (*Vamp*, *Syt*, *Snap*) were also differentially expressed.

### Oxidative insult-related genes

Transcriptomic data revealed an elevated expression of genes related to GSH biosynthesis namely *Gstm1*, *Mgst1*, *Gss* and *Gpx1*. This was accompanied by a brief expression of *Txnrd1* at 8 hrs and a prolonged expression of antioxidant enzyme genes which include superoxide dismutase (*Sod2* and *Sod3*) and peroxiredoxin (*Prdx6*). Moreover, heat shock proteins (*Hspa2*, *Hspb1*, *Hspb8*, *Hspb6*, *Hspca*), that serve as molecular chaperones were also significantly up-regulated (except *Hspa5*).

### Cell cycle and death genes

There was a diminished expression of various pro-apoptosis genes such as *Apaf1* and *Casp 3*, *11 and 12* with the exception of *Csap6*.

In addition, *Bnips*, a group of pro-apoptosis *Bcl-2* family proteins, were also significantly down-regulated. Accordingly, increased gene expression of *Rap1a* and *Braf* might represent activation of MEK/ERK pro-survival signalling pathway. Intriguingly, a series of cell cycle proteins were differentially regulated and some examples of which include *Aurkb*, a range of cyclins and few transcriptional and translational factors. The significance of changes in expression of these cell cycle genes in the absence of visible cell death upon axotomy is intriguing as there is increasing evidence showing that cell cycle proteins do play novel, alternate neuronal functions \[[@b19]\].

### Ion homeostasis response genes

Disruption to ion balance after axotomy was reflected in the varied expression of genes that control ion entry channels such as *Fxyd1*, *Adra1b*, *Edg2*, *Itpr1*, *Trpv4* and *Avpr1a*. In particular, we noticed an elevated gene expression of calcium-activated proteins such as *Capn3* and *S100A1* that play pivotal roles in cell death, axonal resealing and cytoskeleton remodelling. Temporal expression of calcium-associated members such as *Camk2b*, *PKC* and *Grin1* further demonstrated a likely link between calcium levels and neurorepair. Furthermore, elevated gene expression of calcium-activated *AMPK*, a key regulator of energy balance, and its upstream activators namely *Cntf* and interleukins might signify a mechanism in place to compensate energy deficits during ion and/or metabolites imbalance states.

### Inflammatory response genes

Inflammation is part of a complex 'double-edged sword' response to injury that facilitates healing and/or elicits death. Quite interestingly, the presence of inflammation-causing genes such as *Bf*, *C2*, *Atrn* and *Ncf1* was accompanied by an increased expression of cAMP regulatory genes namely *Adcy*, *Adcyap*, *Gpr* and *Rapgef*. Interplay of various chemokines and cytokines was evident from the gene regulation profiles of numerous chemokine ligands (*Ccl* and *Cxcl* families), cytokine (*II1b*), and their receptors (*Cxcr*, *II1r2* and *II6r*). Cytokine-activated transcription factors such as *Stat3* and *c-fos* that drive cell proliferation, signal transduction and cytoskeleton restructuring were also increased.

Validation of microarray analysis
---------------------------------

Microarray data for all time points after axonal injury were validated by RT-PCR against selected genes as presented in [Table 2](#tbl2){ref-type="table"}. The trend of gene expression changes for each selected target obtained from RT-PCR was similar to its microarray data. In general, this confirmed the reliability of the gene expression profiles attained.

###### 

Validation of microarray data using real-time PCR technique on rat neuronal samples, 8, 15, 24 and 48 hrs after axotomy

                                                             **8 hrs**                15 hrs                     24 hrs                     48 hrs        
  ------------------------------------------------- -------- ------------ ----------- ------------- ------------ ------------- ------------ ------------- ------------
  Neural Wiskott--Aldrich syndrome protein          N-WASP   3.7 ± 1.3    7.4 ± 2.4   4.8 ± 1.6     2.7 ± 0.5    3.5 ± 2.1     1.7 ± 0.4    4.2 ± 2.4     2.9 ± 0.3
  Chemokine (C-X-C motif) ligand 10                 Cxcl10   2.7 ± 1.4    2.5 ± 0.8   10.3 ± 23.6   11.1 ± 3.3   3.9 ± 2.9     3.9 ± 2.5    3.9 ± 3.1     2.6 ± 0.8
  Dynein, cytoplasmic, light chain 2B (predicted)   Dncl2b   20.8 ± 6.6   9.3 ± 2.3   23.9 ± 7.2    10.4 ± 3.5   16.4 ± 13.5   10.4 ± 3.9   22.5 ± 10.6   10.0 ± 1.7
  Guanylate nucleotide binding protein 2            Gbp2     17.5 ± 7.1   7.8 ± 3.6   20.0 ± 6.9    9.2 ± 2.8    14.0 ± 3.8    11.4 ± 5.0   12.9 ± 4.7    9.9 ± 2.9
  Chemokine (C-X-C motif) ligand 11                 Cxcl11   5.2 ± 1.7    3.2 ± 1.1   6.0 ± 8.9     4.8 ± 1.7    2.8 ± 0.8     4.8 ± 1.3    2.3 ± 1.3     4.0 ± 1.1
  Aurora kinase B                                   Aurkb    5.0 ± 2.0    3.7 ± 1.0   5.9 ± 1.7     5.4 ± 1.3    4.0 ± 1.6     5.0 ± 1.2    5.8 ± 1.7     4.8 ± 1.6

Data are expressed as fold-change ± S.E.

Discussion
==========

Severance of fasciculated axonal bundles in mature rat neuronal clusters in culture has been used previously to study and characterize the cytoskeletal dynamics of regenerative sprouting after axonal injury \[[@b6]\]. Using the same *in vitro* model, we have applied a DNA microarray approach to gain mechanistic insight into the key molecular determinates that underlie neurite regeneration after axotomy at a transcriptomic level. Briefly, we found that regenerative sprouting is a complicated process that involves complex cytoskeleton dynamics and vigilant control of secondary processes such as oxidative stress, ion homeostasis and inflammation. These secondary processes have to be tightly regulated to ensure neurite regeneration without causing evident cell death. Physiologically, diffuse axonal injury is one of the many key pathological features associated with head trauma. Upon trauma, stretched axons become brittle and tear. This situation is immediately salvaged by the damaged neurons' intrinsic capacity to regenerate. However, mechanisms are activated for cell demise when the injury is beyond redemption. Through transcriptomic studies, we may identify crucial cellular pathways that facilitate regeneration and manipulate them whenever necessary to lessen damage and avoid irreversible apoptosis.

Neurite cytoskeleton reorganization
-----------------------------------

In accordance with the study by Chuckowree and Vickers \[[@b6]\], we confirmed that adaptive sprouting of neurons after injury involves substantial cytoskeleton reorganization. For an axon to regenerate, its neurite arm, which is predominately composed of microtubules, needs to be extended accordingly. This involves microtubule formation and stabilization. Tubulins are fundamental for microtubule formation and this could explain their augmented gene expression. Stabilizing these newly formed microtubules is pivotal and this entails a concerted regulation of various microtubule destabilizing and stabilizing proteins. Elevated gene expression of *Notch1*, alongside decreased expression of *Stmn*, *Cspg2* and *Spg4*, is consistent with this process. It has been found that microtubule stabilization could promote axon regeneration by preventing chondroitin sulphate proteoglycan (*Cspg*) accumulation at lesion site \[[@b20]\]. This stabilization could be mediated by *Notch* activation whereby it down-regulated spastin (*Spg*) expression, a microtubule severing protein, and deterred axonal degeneration in primary cortical neurons \[[@b21]\]. Stamins (*Stmn*) in general destabilize microtubules by preventing their assembly and promoting their disassembly.

The regenerating growth cone acts such as a molecular conveyor belt whereby actin bundles at the proximal end are constantly fragmented by actin-destabilizing or severing proteins. Released actin fragments are then retrogradely transported and reassembled at the leading edge with help from nucleation-promoting factors \[[@b22]\]. These changes were reflected by the down-regulated gene expression of actin regulators namely *Pfn*, *Cdc42*, *Arp2/3* \[[@b23], [@b24]\]. In contrast, *NWASP* and *Gas7* gene expression were up-regulated by an average of 3- and 1.5-fold, respectively, throughout \[[@b25], [@b26]\]. As such, it is imperative to account for the contrasting regulation of *NWASP*, *Arp2/3* and *Cdc42*. *NWASP* and *Arp2/3* are undeniably the master components of actin polymerization. During neurite regrowth, actin dynamics unlike microtubules steer towards instability, a phenomenon observed due to the complex processes governing polymerization and depolymerization of actin filament to support growth cone steering. Interestingly, Erin D.G and Matthew D.W critically reviewed that the way *Arp2/3* affects actin polymerization is more dependent on its activity regulated by ATP rather than its expression \[[@b27]\]. It was mentioned that binding of *WASP* to ATP bound *Arp2/3* and G actin, primes the complex and creates a nucleation point for daughter filaments formation. Subsequent ATP hydrolysis on *Arp2* after nucleation has been temporally and functionally linked to actin branch disassembly. The authors also brought up the importance of recycling *Arp2/3* itself for the formation of new actin processes, an event closely associated with actin recycling. With that, the possibility of regulating already expressed *Arp2/3* proteins by ATP in neurons and the fact that it can be recycled could potentially explain the redundant need for its expression after axotomy. Unlike *Arp2/3*, *NWASP* is not directly regulated by ATP binding but its relevance is to elicit an active conformation of *Arp2/3* for nucleation by physically binding to it. As such, our data illuminate an interesting questionnaire on how *NWASP* is being regulated in regards to neurite regeneration. Moreover, apart from *NWASP* physical interaction with *Arp2/3* to direct actin polymerization, it also serves as focal points where transduced signals converge to orchestrate actin polymerization dynamics \[[@b28]\]. Hence, *NWASP* importance in connecting multiple signalling pathways to initiate actin assembly as well as how it is regulated could possibly account for its elevated expression in comparison to *Arp2/3*. As for *Cdc42*, unlike *NWASP* and *Arp2/3*, there has been evidence showing that *NWASP* recruitment of *Arp2/3* that results in the formation of membrane protrusions and processes could occur *via* a *Cdc42*-independent manner, at least for neurite outgrowth of hippocampal neurons \[[@b26]\]. Because of the way actin proteins are recycled in the growth cone, this further explains the redundant need for newly synthesized actins and they were generally down-regulated transcriptionally following axonal injury. Recycling is essential to prevent excessive actin build-up that could thwart neuronal advances. This assumption is further supported by the heightened expression of myosin genes, which encode motor molecules that transport actins in a retrograde fashion. Using fluorescent speckle microscopy, it was found that inhibition of myosin II not only perturbed actin retrograde flow and affected neuronal growth but its contraction forces were also required to recycle actin fragments for growth cone formation \[[@b29]\]. Together, our gene profiling data showed that neurite regeneration is an event that involves stabilization of microtubules and dynamic instability of actin filaments \[[@b7]\].

Further evidence of the dynamic response of the cytoskeleton to axotomy was the elevated expression of *Tekt 1* and *2*. These represent a group of cilia microtubule structural proteins, and supports an unexpected discovery that neuronal cilia might be vital for modulating signalling pathways to coordinate neuronal processes such as axonal guidance \[[@b30]\]. This highlights the need for further investigation on the roles of cilia-associated proteins in neurobiological events such as axotomy.

The importance of protein trafficking in axonal regeneration was indicated by the varied gene expression of motor proteins involved in cytoskeletal transport such as *Dnc*, *Dna*, *Kif*, *Myh*, *Tpm* and machinery factors linked to membrane vesicles such as *Syt*, *Vamp*, *Stx*. This clearly illustrated retrograde transport of injury signals from cut site to cell body which then evoked membrane expansion processes that involve cargo trafficking of cytoskeletal proteins and even neurotropic factors to promote axonal re-growth. Dynein-derived forces in particular, are able to oppose axon retraction and permit microtubules to advance \[[@b31]\].

Moreover, neurite regeneration is a process that involves reciprocal regulation of permissive and repulsive axon guidance cues. Neurotrophic factors, for instance, are capable of directing axonal regrowth in damaged neurons. *Bdnf* can sustain axon regeneration upon various nerve and brain injuries \[[@b32], [@b33]\] and overexpression of its receptor *NtrkB* was also found to elicit corticospinal axonal regeneration \[[@b34]\]. Here, transient gene expression of *Bdnf* and *Ntrks* at 8 hrs could highlight the probable importance of these molecules in the recovery process during the initial phase but not as much after specific projections had been formed. Most repulsive guidance molecules on the other hand, inhibit and deter axonal regrowth after injury. *Sema3a* is one such example. Chemically inhibiting *Sema3a* prevented its binding to neuropilin and enhanced neural regeneration in damage axons \[[@b35]\]. *Eph/Ephrin* signalling which controls axon guidance by contact repulsion also inhibits regeneration of axons following injury in neurons \[[@b36]\]. Similarly, our transcriptomic data concurred that these molecules and their receptors mainly *Efn*, *Sema*, *Slit*, *Bmp*, *Nrp*, *Plxd* and *Eph* were not favoured during neurite regrowth.

Notably, some neurite promoting factors including *Apoe*, *Cntf* and *Lama5* were also significantly up-regulated. *Apoe* is required for lipid delivery for axon regrowth upon nerve crush injury \[[@b37]\] whereas *Lama* serves as a crucial extracellular matrix adhesion molecule along which axons would grow and thus permit regeneration in central neurons \[[@b38], [@b39]\]. Although *Cntf* is found mainly in astrocytes, it is also expressed in cortical neurons \[[@b40]\]. Being a cytokine-induced neurotrophic factor, it can potentiate axon regeneration in optic and spinal nerve injuries \[[@b41]-[@b43]\]. Overall, our results demonstrate that to facilitate axonal regrowth, the injured neurons themselves adapt to ensure that the cellular environment is permissive to regeneration *via* temporal generation of positive cues, concomitant restriction of negative cues and expression of neurotrophic factors.

Apart from the genes that regulate neurite cytoskeleton, our data have further shown that various genes commonly linked to secondary processes such as oxidative stress, apoptosis, cell cycle, calcium homeostasis and inflammation are also important in dictating the regenerative process of axonally cut neurons and their possible roles are briefly discussed as follow.

Oxidative stress
----------------

Reactive oxygen species (ROS) are inevitable harmful by-products of cellular activities. Oxidative stress, which could result in cell death, ensues when the build-up of ROS in cells overwhelm existing biological antioxidants under normal conditions. This occurs in neurons after axonal injury. To counteract such insult, our study showed that genes responsible for GSH synthesis and various antioxidant enzymes (*Sods*, *Prdxs*, *Gpx*) were elevated to alleviate the stress. This demonstrated that neurons have the transcriptional capability to activate these vital mechanisms for their fight against oxidative insult to prevent death and assist in regenerative sprouting.

Several heat shock proteins (*Hsp*) were also transcriptionally up-regulated. Mainly, *Hsp* act as molecular chaperones to refold misfolded proteins and prevent deleterious protein build-up. Intriguingly, small *Hsp* (12--43 kD) are viewed as vital neuroprotectants in several neurological disorders \[[@b44]\]. *Hsp27* whose gene expression was up-regulated by ≥4-folds post-injury could suppress cytochrome *c*--mediated cell death \[[@b45]\]. Besides, it could interact, modulate and remodel neuronal cytoskeleton \[[@b46], [@b47]\]. As such, in addition to its protein refolding function, local gene expression of *Hsp* after axotomy might serve as anti-apoptotic and neurite regrowth signals.

Programmed cell death (PCD)
---------------------------

PCD is a process regulated by proto-oncogenes. It is logical that for an injured neuron to successfully regenerate, it must avoid axotomy-induced cell death. It is possible that apoptotic genes such as *Apaf1*, *Bnips*, *Casp3*, *11* and *12* were down-regulated in our study as an intrinsic protective mechanism to facilitate regeneration. This is supported by the fact that axotomized neuronal clusters *in vitro* did not result in evident cell death \[[@b6]\]. Similarly, studies have shown that overexpression of anti-apoptotic proteins could save neurons from axotomy-induced cell death \[[@b48], [@b49]\]. However, it is important to note that stringent control of apoptotic genes expression in denial of cell death in this case does not necessarily assist or speed up neurite regeneration, and probably indicates that neuron survival and neurite regeneration represent two distinct, although closely linked, processes within axotomized neurons.

Cell cycle
----------

Cell cycle activation in response to DNA damage during extreme cellular stress could lead to the demise of neurons \[[@b50]\]. Interestingly, several cell cycle proteins were recently found to possess distinct, alternate neuronal functions that are independent from their cell cycle roles \[[@b19]\]. Plausibly, this mirrors our case of neurite regeneration in which certain cell cycle genes were elevated despite the down-regulation of several apoptotic genes consistent with cell death not being prominent. *Aurkb*, for example is a cell cycle kinase that remodels microtubule arrays for precise cell division \[[@b51], [@b52]\]. Its elevated gene expression could possibly reflect a function in neurite regrowth, a process akin to its involvement in cell division, because both processes involve complex cytoskeleton reorganization. However, functional biological studies are required to ascertain this speculation. Intriguingly, Aurora A kinase (*Aurka*), a sister kinase of *Aurkb* that is also known for its mitotic roles, had lately been reported by two separate groups to play a crucial role in the establishment of neuronal polarity \[[@b53], [@b54]\].

A more specific example involves *Klf4*, which was significantly down-regulated in our studies. Early studies show that *Klf4* is a key cell cycle checkpoint transcription factor and it causes G~1~/S arrest by activating genes that are potent inhibitors of proliferation \[[@b55]\]. Recently, an alternate neuronal function of *Klf4* was discovered whereby its overexpression in cortical neurons impeded neurite outgrowth while its knockout in retinal ganglion cells (RGCs) increased axon regeneration after crush injury \[[@b56]\]. Hence, beside cell cycle re-entry causing neuronal death, diverse gene expression of cell cycle proteins after axotomy could also signify alternate and unexpected functions for these proteins to regulate the cytoskeleton and promote axonal regeneration.

Calcium homeostasis
-------------------

Calcium homeostasis after axotomy is vital as it determines survival or cell death onset. When the damage is too severe, excitotoxicity due to excessive influx of calcium ions causes neuronal cell death. However, in less damaging situations where calcium levels are appropriately controlled, this triggers proteolysis and membrane fusion/fission processes associated with axonal repair and cytoskeleton reorganization. First, local resealing is a critical early response for regrowth and this requires calcium activation of calpains to cleave the spectrin network and release membrane tension. This might explain why *Capn3* was up-regulated, whereas *Spnb* gene expression was varied. Secondly, calcium is a fundamental co-factor for cytoskeletal remodelling as it is required for membrane vesicle fusion processes used in the delivery of constructive molecules and neurotrophic factors to axotomized ends for resealing purposes and growth cone formation \[[@b57]\]. Varied gene expression of calcium signalling associated genes, and the elevated gene expression of motor and machinery proteins involved in membrane vesicle transport and fusion mentioned earlier, further supported this supposition.

In addition, up-regulation of *SNF1/AMPK*, a calcium-activated kinase involve in metabolic stress, showed that energy level regulation after axotomy is important. This is accompanied by the concomitant elevated expression of its upstream activators such as *Il-6* and *Cntf* \[[@b58], [@b59]\]. Research on the role of *AMPK* in neurons is new but recent studies have shown that *AMPK* activation in neurons is neuroprotective \[[@b60], [@b61]\]. More recently, plausible roles for *AMPK* in neuronal polarity and axon specification are indicated by its necessity for the maintenance of cell polarity in epithelial cells \[[@b62]\]. In the case of our study, it is possible that energy regulation in response to calcium ion levels could be crucial for the battle against metabolic insults and the re-establishment and/or maintenance of polarity in severed neurons.

Inflammation
------------

Inflammation in response to axotomy as observed from the presence of *Bf, C2, Nrf1* and *Atrn* could result in cell death if not properly regulated \[[@b63]-[@b65]\]. cAMP levels which are increased and limited by the activity of adenylate cyclase (*Adcy*) and phosphodiesterase (*Pde*), respectively, could mitigate inflammation \[[@b66], [@b67]\]. Elevated gene expression of *Adcy*, *Adcyap* and *Gpr*, but decreased expression of *Pde*, as per our study, clearly suggested that cAMP elevation was adopted to ease inflammation caused by axotomy. More important, increased levels of cAMP were found to promote axonal regeneration and recovery after CNS injury \[[@b68]\]. The likely mechanism for this is increasing the translocation of neurotrophic receptors, for example *NtrkB*, to the plasma membrane of neurons \[[@b69]\]. cAMP could also activate a series of kinases that augment growth promoting signalling pathways in brain and spinal cord injuries \[[@b70]\]. Our data confirm the importance of the role of cellular cAMP level to alleviate inflammation and to push regrowth mechanisms in response to injury. Henceforth, the roles of ATP in *Arp2/3* regulation mentioned earlier, together with the significance of regulating secondary messengers to direct neurite regeneration, highlight the importance of secondary messenger precursors in the study of axonal injury.

Apart from the primary association of cytokines and chemokines with inflammation, they could also directly or indirectly modulate regeneration after injury. This was evident from their robust gene expression profiles. Through a knockout study, *Il6*, a cytokine, was found to promote re-growth of dorsal column axons after static nerve injury \[[@b71]\]. Changes in cytokine levels often alter expression of transcription factors involved in inflammation and regeneration. *Stat3* is one such example and its activation in axons upon injury could act as a retrograde signalling factor to promote regeneration of sensory and motor neurons \[[@b72]\]. As for chemokines, *Cxcr4* for instance, was implicated with neuronal regeneration because it could regulate axonal path finding in the CNS \[[@b73]\]. Notably, *Il6r*, *Stat3* and *Cxcr4* were all transcriptionally up-regulated in our study. These examples highlight the direct impact cytokines and chemokines can have upon regenerating neurons.

Physiologically however, cytokines and chemokines released upon neuroinflammation often have an indirect effect on neurons whereby they help to recruit immune-response cells to injured site. Most of these cells when recruited excessively to injured site could result in neuronal apoptosis but during regeneration, they could also secrete bioactive forms of neurotrophic factors that would potentially aid in neurons' axon regrowth \[[@b74]-[@b76]\]. Supplementation of neurite promoting factors by immune cells could possibly explain the transient need for neurons to express their own, such as *Ntrk* and *Bdnf* found in our *in vitro* injury model. Intriguingly, a study showed that oncomodulin secreted by inflammation-activated macrophages could promote axon regeneration in RGCs only upon elevated cAMP levels \[[@b77]\]. It was speculated that increased cAMP caused translocation of specific receptors to the cell surface membrane. Even though this was observed in RGCs, the general idea may still apply for neurons in which they are probably programmed to modulate cellular second messenger levels, such as cAMP, during injury to elicit actions. For example, relocation of specific receptors to the cell membrane in anticipation of binding to neurite-promoting factors released by surrounding immune-response cells.

Conclusion
==========

It is significant that a number of genes listed in our DNA microarray study were in accordance with findings from previous *in vitro* and *in vivo* regenerative studies reported by other groups in relation to spinal cord and brain injuries. This provides affirmation that our protocol of severing axonal bundles *in vitro* to study injury-induced neurite regeneration is a reasonable and valid experimental model. From a transcriptomic view, we have revealed that neurite regeneration is a complex process that mainly involves restructuring of neurite cytoskeleton, determined by intricate actin and microtubule dynamics, protein trafficking and appropriate control of both guidance cues and neurotrophic factors. We conclude that the molecular response of neurons to axotomy is not a simple process and evokes two distinct pathways; a cell survival response accompanied by activation of genes to protect against oxidative stress, inflammation and cellular ion imbalance and a regenerative response driven by modulation of the neuronal cytoskeleton. Gene expression profiles from our study demonstrated that injured neurons have an innate capability to survive axotomy by elevating biological antioxidants and molecular chaperones, regulating secondary messengers, suppressing apoptotic genes, controlling calcium ion-associated processes and possibly by expressing certain cell cycle proteins which might serve unique alternate neuronal functions. Genes involved in these highlighted protective and regenerative mechanics were summarized in [Figure 3](#fig03){ref-type="fig"}. Transcriptional analysis is a powerful and effective screening method to globally search for comprehensive clues to determine which biological pathways are involved in the intrinsic response of neurons to axotomy. Appropriate manipulation of selected biological targets involved in these pathways could then potentially facilitate the design and development of novel, effective therapeutics for axonal damage in CNS injury.
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